MedTrace Logo

ATX Register Accolade Stem & Trident/Tritanium Cup With X3 Insert

NCT02520544 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 472

Last updated 2026-01-26

Study results available
· View outcomes & findings →

Summary

The aim of this register is to determine the Accolade/Accolade II stem and Trident/Tritanium cup survivorship over years.

Conditions

  • Arthroplasty, Replacement, Hip

Interventions

DEVICE

Accolade stem

Total hip replacement

DEVICE

Accolade II stem

Total hip replacement

DEVICE

Trident/Tritanium cup

Total hip replacement

Sponsors & Collaborators

  • Stryker Orthopaedics

    lead INDUSTRY

Principal Investigators

  • Stefan Bolder, MD · Amphia Zieknhuis Breda

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2024-11-12
Completion
2024-11-12

Countries

  • Belgium
  • Netherlands
  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02520544 on ClinicalTrials.gov